Acta Med. 2013, 56: 3-8

https://doi.org/10.14712/18059694.2014.30

THE MANAGEMENT OF CHARCOT MIDFOOT DEFORMITIES IN DIABETIC PATIENTS

Pavel Šponera,b, Tomáš Kučeraa,b, Jindra Brtkovác, Jaromír Šrotb

aCharles University in Prague, Faculty of Medicine in Hradec Králové, Czech Republic: Department of Orthopaedic Surgery
bUniversity Hospital in Hradec Králové, Czech Republic: Department of Orthopaedic Surgery
cUniversity Hospital in Hradec Králové, Czech Republic: Department of Diagnostic Radiology

References

1. Adams CA, Deitch EA. Diabetic foot infections. In: Holzheimer RG,Mannick JA, eds. Surgical treatment: evidence-based and problem-oriented. Munich: Zuckschwerdt, 2001.
2. Anderson JJ, Woelffer KE, Holtzman JJ et al. Bisphosphonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surg 2004; 43: 285–9. <https://doi.org/10.1053/j.jfas.2004.07.005>
3. Armstrong DG, Lavery LA. Monitoring healing of acute Charcot’s arthropathy with infrared dermal termometry. J Rehabil Res Dev 1997; 34: 317–21.
4. Armstrong DG, Todd WF, Lavery LA et al. The natural history of acute Charcot’s arthropathy in a diabetic foot speciality clinic. Diabet Med 1997; 14: 357–63. <https://doi.org/10.1002/(SICI)1096-9136(199705)14:5<357::AID-DIA341>3.0.CO;2-8>
5. Assal M, Stern R. Realignment and extended fusion with use of a medial column screw for midfoot deformities secondary to diabetic neuropathy. J Bone Joint Surg Am 2009; 91: 812–20. <https://doi.org/10.2106/JBJS.G.01396>
6. Bem R, Jirkovská A, Fejfarová V et al. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial. Diabetes Care 2006; 29: 1392–4. <https://doi.org/10.2337/dc06-0376>
7. Beno M, Martin J, Sager P. Vacuum assisted closure in vascular surgery. Bratisl Lek Listy 2011; 112: 249–52.
8. Boninger ML, Leopard JA. Use of bivalved Antle foot orthosis in neuropathic foot and ankle lesion. J Rehabil Res Dev 1996; 33: 16–22.
9. Bono JV, Roger DJ, Jacobs RL. Surgical arthrodesis of the neuropathic foot: A salvage procedure. Clin Orthop Rel Res 1993; 296: 14–20.
10. Brodsky JW, Rouse AM. Exostectomy for symptomatic bony prominence in diabetic Charcot feet. Clin Orthop Rel Res 1993; 296: 21–6.
11. Buse JB, Ginsberg HN, Bakris GL et al. American Heart Association; American Diabetes Association. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care 2007; 30: 162–72. <https://doi.org/10.2337/dc07-9917>
12. Catanzariti AR, Mendicino R, Haverstock B. Ostectomy for diabetic neuroarthropathy of the midfoot. Am J Orthop 2007; 39: 291–300.
13. Cornblath DR. Diabetic Neuropaty: Diagnostic methods. Adv Stud Med 2004; 4: S650–61.
14. Ducic I, Attinger CE. Foot and ankle reconstruction: pedicled muscle flaps versus free flaps and the role of diabetes. Plast Reconstr Surg 2011; 128: 173–80. <https://doi.org/10.1097/PRS.0b013e3182173d3a>
15. Dungl P. Ortopedie. 1st ed. Praha: Grada Publishing, 2005: 1161–4.
16. Farber DC, Juliano PJ, Cavnagh PR et al. Single stage correction with external fixation of the ulcerated foot in individuals with Charcot neuroarthropathy. Foot Ankle Int 2002; 23: 130–4. <https://doi.org/10.1177/107110070202300209>
17. Jeffcoate W. The cause of the Charcot syndrome. Clin Podiatr Med Surg 2008; 25: 29–42. <https://doi.org/10.1016/j.cpm.2007.10.003>
18. Jeffcoate WJ, Game F, Cavanagh PR. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet 2005; 366: 2058–61. <https://doi.org/10.1016/S0140-6736(05)67029-8>
19. Kučera T, Urban K, Šponer P. Charcot arthropathy of the knee. A case-based review. Clin Rheumatol 2011; 30: 425–8. <https://doi.org/10.1007/s10067-010-1617-x>
20. Laurinaviciene R, Kirketerp-Moeller K, Hostein PE. Exostectomy for chronic midfoot plantar ulcer in Charcot deformity. J Wound Care 2008; 17: 53–5. <https://doi.org/10.12968/jowc.2008.17.2.28178>
21. Marks RM, Parks BG, Schon LC. Midfoot fusion technique for neuropathic feet: biomechanical analysis and rationale. Foot Ankle Int 1998; 19: 507–10. <https://doi.org/10.1177/107110079801900801>
22. Mittlmeier T, Klaue K, Haar P et al. Should one consider primary surgical reconstruction in Charcot arthropathy of the feet? Clin Orthop Relat Res 2010; 468: 1002–11. <https://doi.org/10.1007/s11999-009-0972-x> <PubMed>
23. Morgan JM, Biebl WC, Wanger FW. Management of neuropathic arthropathy with the Charcot restraint orthotic walker. Clin Orthop Rel Res 1993; 296: 58–63.
24. Morrison WB, Ledermann HP. Work-up of the diabetic foot. Radiol Clin North Am 2002; 40: 1171–92. <https://doi.org/10.1016/S0033-8389(02)00036-2>
25. Mueller MJ, Sinacore DR, Hastings MK et al. Impact of Achilles tendon lengthening on functional limitations and perceived disability in people with a neuropathic plantar ulcer. Diabetes Care 2004; 27: 1559–64. <https://doi.org/10.2337/diacare.27.7.1559>
26. Pinzur MS. Neutral ring fixation for high-risk nonplantigrade Charcot midfoot deformity. Foot Ankle Int 2007; 28: 961–6. <https://doi.org/10.3113/FAI.2007.0961>
27. Pitocco D, Ruotolo V, Valuto S et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care 2005; 28: 1214–1215. <https://doi.org/10.2337/diacare.28.5.1214>
28. Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg 1998; 176: 5S–10S. <https://doi.org/10.1016/S0002-9610(98)00181-0>
29. Rogers LC, Frykberg RG, Armstrong DG et al. The Charcot foot in diabetes. J Am Pod Med Ass 2011; 101: 437–46. <https://doi.org/10.7547/1010437>
30. Rooney J, Hutabarat S, Grujic L, Hansen S. Surgical reconstruction of the neuropathic foot. The foot 2002; 12: 213–23. <https://doi.org/10.1016/S0958259202000706>
31. Sammarco VJ, Sammarco GJ, Walker EW, Guiao RP. Midtarsal arthrodesis in the treatment of Charcot midfoot arthropathy. J Bone Joint Surg Am 2009; 91: 80–91. <https://doi.org/10.2106/JBJS.G.01629>
32. Singh R, Bhalla A, Sachdev A, Lehl SS. Diabetic Neuropathic Arthropathy. Int J Diab Dev Countries 2000; 20: 135–8.
33. Wagner F. A classification and treatment program for diabetic, neuropathic, and dysvascular foot problems. Instr Course Lect 1979; 28: 143–65.
34. Waters R, Perry J, Chambers R. Energy expenditure of amputee gait. In: Moore W, Malone JM, eds. Lower extremity amputation. Philadelphia: W B Saunders, 1989: 250–60.
35. Wukich DK, Belczyk RJ, Burns PR. Complications encoutered with circular ring fixation in persons with diabetes mellitus. Foot Ankle Int 2008; 29: 994–1000. <https://doi.org/10.3113/FAI.2008.0994>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive